Speak to the pharma team
01628 581 240
Speak to the healthcare team
01225 336 335
Speak to the clinical team
01628 581 240
Speak to the contract team
01225 336 335
Speak to us about Master Vendor
01225 336 335
Or send your enquiry via email and the best person to help will be in touch.
solutions@starmedical.co.uk
Otsuka Europe is a specialist in devices and pharmaceuticals that address unmet medical needs in particular mental illness, cardiovascular, gastro intestinal and central nervous system disorders. Based on the philosophy "Otsuka people creating new products for better health worldwide." Otsuka launched in Germany in 1982.
Otsuka believe the key to success is to provide the right environment for research. In Japan, Dr Tetsuro Kituchi spent years trying to find a schizophrenia treatment. Otsuka provided the optimum environment and this led to a breakthrough in schizophrenia research.
Otsuka's product for mental health, Abilify has won the Prix Galien for the Most Innovative Product on the retail market in France.
Abilify has won 8 industry awards for innovation and is co-marketed with Bristol Myers Squibb. It is used in the treatment of schizophrenia, acute manic and mixed episodes associated with bipolar disorder. It maintains efficacy in patients with bi polar disorder.
Pletal is used to reduce the symptoms of intermittent claudication (pain in the legs that happens when walking and goes away with rest). Pletal helps people walk a longer distance before leg pain occurs.
